Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jerry Janssen"'
Autor:
Jerry Janssen, Naomi Donner, Zhen Li, Thera A.M. Wormhoudt, Koen Wagner, Jeroen E.J. Guikema, C. Ellen van der Schoot, Arnon P. Kater, Ten Feizi, Richard J. Bende, Carel J.M. van Noesel
Publikováno v:
HemaSphere, Vol 5, Iss 4, p e550 (2021)
Externí odkaz:
https://doaj.org/article/21a1828a83c546e5b5d5fb8ae9d8b8bc
Autor:
Richard J. Bende, Jerry Janssen, Thera A.M. Wormhoudt, Koen Wagner, Jeroen E.J. Guikema, Carel J.M. van Noesel
Publikováno v:
Haematologica, Vol 101, Iss 5 (2016)
Externí odkaz:
https://doaj.org/article/3f5c0c7b75684bbb9f6d293b3c978468
Publikováno v:
British journal of haematology. Wiley-Blackwell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c66af59675f2e976f8b1dc1e2959d4db
https://pubmed.ncbi.nlm.nih.gov/34796956
https://pubmed.ncbi.nlm.nih.gov/34796956
Autor:
Koen Wagner, Richard J. Bende, Naomi Donner, Jerry Janssen, Thera A. M. Wormhoudt, C. Ellen van der Schoot, Ten Feizi, Arnon P. Kater, Jeroen E. J. Guikema, Carel J. M. van Noesel, Zhen Li
Publikováno v:
HemaSphere. Wolters Kluwer Health
HemaSphere, Vol 5, Iss 4, p e550 (2021)
HemaSphere
HemaSphere, Vol 5, Iss 4, p e550 (2021)
HemaSphere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c3c7f9c97d7162d8315c7f112f39351
https://doi.org/10.1097/hs9.0000000000000550
https://doi.org/10.1097/hs9.0000000000000550
Autor:
Koen Wagner, Frans G. M. Kroese, Thera A. M. Wormhoudt, Jeroen E. J. Guikema, Richard J. Bende, Anna Beentjes, Jerry Janssen, Erlin A. Haacke, Carel J. M. van Noesel
Publikováno v:
Arthritis & rheumatology (Hoboken, N.J.), 72(8), 1330-1340. John Wiley and Sons Ltd
Arthritis & Rheumatology, 72(8), 1330-1340. Wiley
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis & Rheumatology, 72(8), 1330-1340. Wiley
Arthritis & Rheumatology (Hoboken, N.j.)
OBJECTIVE: Patients with Sjӧgren's syndrome (SS) have an increased risk of developing malignant B cell lymphomas, particularly mucosa-associated lymphoid tissue (MALT)-type lymphomas. We have previously shown that a predominant proportion of patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19bac0565ffe8047adbece197b9415ad
https://pubmed.ncbi.nlm.nih.gov/32182401
https://pubmed.ncbi.nlm.nih.gov/32182401
Autor:
Thera A. M. Wormhoudt, Carel J. M. van Noesel, Jerry Janssen, Koen Wagner, Jeroen E. J. Guikema, Richard J. Bende
Publikováno v:
Haematologica, 101(5), e200-e203. Ferrata Storti Foundation
Subsets of mucosa-associated lymphoid tissue (MALT) lymphoma, splenic marginal zone B-cell lymphoma (MZBCL) and chronic lymphocytic leukemia (CLL) have been identified that express near-identical B-cell receptors (BCRs), strongly suggesting selection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278d1412c2b97cdeb3ba14744225cd04
https://doi.org/10.3324/haematol.2015.139626
https://doi.org/10.3324/haematol.2015.139626
Autor:
Matheus Dyczynski, Vasilios Zachariadis, Janne Lehtiö, Ann-Charlotte Björklund, Evangelia Daskalaki, Katja Pokrovskaja Tamm, Mattias Vesterlund, Hector Gallart-Ayala, Roland Nilsson, Jerry Janssen, Craig E. Wheelock, Dan Grandér
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 9, Iss 9, Pp 1-13 (2018)
Cell Death and Disease, Vol 9, Iss 9, Pp 1-13 (2018)
Glucocorticoids (GCs) are metabolic hormones with immunosuppressive effects that have proven effective drugs against childhood acute lymphoblastic leukemia (ALL). Yet, the role of metabolic reprogramming in GC-induced ALL cell death is poorly underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80dfa9e7ba6311c2689b4929ee4c848d
https://pubmed.ncbi.nlm.nih.gov/30154400
https://pubmed.ncbi.nlm.nih.gov/30154400
Autor:
Martin Kliment, Quirinus J. M. Voorham, Chris J. J. Mulder, Heike I. Grabsch, Suzanne Snellenberg, Sandra Mongera, Nicole C.T. van Grieken, Beatriz Carvalho, Manon van Engeland, Renske D.M. Steenbergen, Bjorn Rembacken, Gerrit A. Meijer, Jerry Janssen, Marianne Tijssen
Publikováno v:
BMC Cancer, 13(1), 603-611. BioMed Central
BMC Cancer
Voorham, Q J M, Janssen, J, Tijssen, M, Snellenberg, S, Mongera, S, van Grieken, N C T, Grabsch, H, Kliment, M, Rembacken, B J, Mulder, C J J, van Engeland, M, Meijer, G A, Steenbergen, R D M & Carvalho, B 2013, ' Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas ', BMC Cancer, vol. 13, no. 1, pp. 603-611 . https://doi.org/10.1186/1471-2407-13-603
BMC Cancer
Voorham, Q J M, Janssen, J, Tijssen, M, Snellenberg, S, Mongera, S, van Grieken, N C T, Grabsch, H, Kliment, M, Rembacken, B J, Mulder, C J J, van Engeland, M, Meijer, G A, Steenbergen, R D M & Carvalho, B 2013, ' Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas ', BMC Cancer, vol. 13, no. 1, pp. 603-611 . https://doi.org/10.1186/1471-2407-13-603
Background Nonpolypoid adenomas are a subgroup of colorectal adenomas that have been associated with a more aggressive clinical behaviour compared to their polypoid counterparts. A substantial proportion of nonpolypoid and polypoid adenomas lack APC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1ba98950e5be016fa4209a15f3587e
https://research.vumc.nl/en/publications/efdb9482-dd39-4804-982b-b1ab0cdf6969
https://research.vumc.nl/en/publications/efdb9482-dd39-4804-982b-b1ab0cdf6969
